22nd Century Group Meeting To Take Place 11/12/2014

by Eddie Staley, Benzinga Editor
September 25, 2014 7:26 AM | 8 seconds read |
  • BB-1 Cigarette Designed to Provide Low Tar-to-Nicotine Yield Ratio
  • 22nd Century Group, With FDA Concurrence, to Conduct Exposure Study on BB-1 in 1st Quarter
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!